Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Anticancer Research|December 27, 2011
Thioridazine induces apoptosis of multidrug-resistant mouse lymphoma cells transfected with the human ABCB1 and inhibits the expression of P-glycoproteinGabriella Spengler, Joseph Molnar, Miguel Viveiros, et al.
Anticancer Research|October 30, 2016
The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug ThioridazineGabriella Spengler, Ákos Csonka, Joseph Molnár, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 20, 2010
Identification of efflux-mediated multi-drug resistance in bacterial clinical isolates by two simple methodsMarta Martins, Isabel Couto, Miguel Viveiros, et al.
Frontiers in Pharmacology|January 16, 2014
Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with themLeonard Amaral, Ana Martins, Gabriella Spengler, et al.
Molecules (Basel, Switzerland)|March 16, 2017
New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in BacteriaGabriella Spengler, Annamária Kincses, Márió Gajdács, et al.
In Vivo (Athens, Greece)|April 18, 2007
Review. Comparison of multidrug resistant efflux pumps of cancer and bacterial cells with respect to the same inhibitory agentsLeonard Amaral, Helga Engi, Miguel Viveiros, et al.
Recent Patents on Anti-Infective Drug Discovery|May 10, 2011
Effective therapy with the neuroleptic thioridazine as an adjunct to second line of defence drugs, and the potential that thioridazine offers for new patents that cover a variety of "new uses"Leonard Amaral, Miguel Viveiros, Joseph Molnar, et al.
The Open Microbiology Journal|April 10, 2013
Multidrug Efflux Pumps in Staphylococcus aureus: an UpdateSofia Santos Costa, Miguel Viveiros, Leonard Amaral, et al.
Recent Patents on Anti-Infective Drug Discovery|April 27, 2011
Inhibition of drug efflux in mycobacteria with phenothiazines and other putative efflux inhibitorsLiliana Rodrigues, José A Aínsa, Leonard Amaral, et al.
In Vivo (Athens, Greece)|September 26, 2009
Modelling of tumour--host coexistence In vitro in the presence of serine protease inhibitorsHelga Engi, Nóra Gyémánt, Motohiro Ohkoshi, et al.
Pageof 13